AlphaSense
AI-Powered Market Intelligence
New York City, NY, USA
Enterprise search and data analytics company.
How We Help
Problem Statement
Business and financial professionals face challenges making data-driven decisions due to the overwhelming volume and complexity of market information. AlphaSense solves this by providing a unified AI platform for efficient research, analysis, and extraction of critical insights.
Core Technology
AI platform leveraging artificial intelligence (AI), machine learning (ML), and natural language processing (NLP). Key features include Generative Search (with Deep Research), Smart Summaries, Generative Grid, and AI Workflow Agents.
Key Differentiators
Extensive and Proprietary Content Library (over 500 million documents daily), Purpose-Built AI for business and financial research, Advanced AI Features (Generative Search, Deep Research, Smart Summaries, Generative Grid), Unifies Quantitative and Qualitative Insights, Workflow Automation and Collaboration Tools, Enterprise-Grade Security and Scalability, and Strategic Acquisitions (e.g., Tegus, Sentieo, BamSEC, Canalyst).
Clinical Focus
The platform helps professionals in life sciences and healthcare sectors track evolving markets, disease areas, clinical trial pipelines, and regulatory changes. Its AI understands scientific nuances, including drug names and disease classifications, and provides access to critical healthcare sources like FDA, EMA, ClinicalTrials.gov, and PubMed.
Target Customers
Business and financial professionals, professionals in life sciences and healthcare sectors, large enterprise customers.
Product Stage
Mature
Company Info
- Business Model
- B2B, SaaS, Subscription-based
- Founded
- 2011
- Total Funding
- 1,390,000,000
- Website
- www.alpha-sense.com
Categories
Disease Areas
Technologies
MedStartr Index Score
?What do you think of AlphaSense?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.